Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-12-21FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental NDA for a generic calcipotriene and betamethasone dipropionate topical product from Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2018-12-20Clinical Trial Update: The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis
A completed clinical trial investigating how a patient's smoking status impacts the effectiveness of etanercept therapy in chronic plaque ps…
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of DSXS in mild to moderate plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis [Phase 2]
Phase 2 clinical trial assessing potential adrenal suppression following treatment with DSXS in patients with plaque psoriasis; study comple…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study [Phase 2]
Phase 2 randomized trial in plaque psoriasis completed; results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: An Open Label, Safety Study to Assess the Potential for Adrenal Suppression [Phase 2]
Phase 2 open-label safety study assessing potential adrenal suppression in plaque psoriasis; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-26Clinical Trial Update: A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306) [Phase 3]
Phase 3 trial comparing 122-0551 Foam to vehicle foam in plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310) [Phase 3]
Phase 3 trial comparing 122-0551 foam to vehicle foam in plaque psoriasis. Study completed with results posted in 2018.
-
FDA approval · 2018-11-06FDA Approved: BRYHALI — Original Application (Bausch Health US, LLC)
FDA approved Bryhali, the brand-name halobetasol propionate topical product, under an original NDA by Bausch Health US, LLC.
-
FDA approval · 2018-11-05FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved the original application for Fluocinonide Acetonide (a generic topical corticosteroid) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2018-10-30FDA Approved: ADALIMUMAB — Original Application (Sandoz Inc)
FDA approved the original application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc. The approval covers the same indication…
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating efficacy and safety of 122-0551 in subjects with plaque psoriasis has completed with results posted.
-
FDA approval · 2018-10-23FDA Approved: DESOXIMETASONE — Original Application (The J. Molner Company LLC)
FDA approved the original ANDA for desoximetasone, a topical corticosteroid, from The J. Molner Company LLC.
-
FDA approval · 2018-10-16FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2018-10-09FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for SILIQ (brodalumab) filed by Bausch Health US LLC, updating the product's labeling to reflect…
-
FDA approval · 2018-10-03FDA Approved: ENBREL — Supplemental Application (Immunex Corporation)
FDA approved a supplemental application for Enbrel (etanercept) submitted by Immunex Corporation. The approval updates the labeling as descr…
-
CLINICAL_TRIALS trial_result · 2018-10-03Clinical Trial Update: Safety and Efficacy Study Comparing AM001 Cream, 7.5% to Vehicle Cream in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating AM001 7.5% cream vs vehicle for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis [Phase 3]
Phase 3 trial comparing 122-0551 foam to vehicle foam in plaque psoriasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 pediatric trial assessing safety, tolerability, and pharmacokinetics of apremilast (CC-10004) in moderate-to-severe plaque psoriasis…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression [Phase 2]
Phase 2 clinical trial update on pharmacokinetics of 122-0551 and its effects on adrenal suppression in plaque psoriasis.
-
CLINICAL_TRIALS research · 2018-09-24Clinical Trial Update: Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
Non-interventional, long-term study of calcipotriol plus betamethasone gel for psoriasis; completed with posted results in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis [Phase 3]
Phase 3 trial update for M923 in combination with Humira in chronic plaque-type psoriasis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis [Phase 3]
A Phase 3 trial comparing tazarotene 0.05% cream to TAZORAC® (tazarotene) 0.05% cream and to placebo in plaque psoriasis has completed with …
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast [Phase 4]
Phase 4 trial evaluating the efficacy of etanercept in adults with plaque psoriasis who failed apremilast therapy has completed with results…
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) [Phase 3]
Phase 3 trial evaluating two dose levels of certolizumab pegol for plaque psoriasis; study completed with results posted in 2018.